Global Anticancer Drugs Outlook: Discovering Opportunities to 2020

WA, Aug. 9, 2017 / QYResearch Global/ -- QYResearch: Global Anticancer Drugs Market will reach 173.23 billion USD in 2022

Anticancer Drugs are used to treat malignancies, or cancerous growths. Drug therapy may be used alone, or in combination with other treatments such as surgery or radiation therapy.
Anticancer Drugs are used to control the growth of cancerous cells. Cancer is commonly defined as the uncontrolled growth of cells, with loss of differentiation and commonly, with metastasis, spread of the cancer to other tissues and organs. Cancers are malignant growths. In contrast, benign growths remain encapsulated and grow within a well-defined area. Although benign tumors may be fatal if untreated, due to pressure on essential organs, as in the case of a benign brain tumor, surgery or radiation are the preferred methods of treating growths which have a defined location. Drug therapy is used when the tumor has spread, or may spread, to all areas of the body.
At present, most common solid tumors, such as lung cancer, liver cancer, colon cancer and pancreatic cancer, still lack effective drugs, and many Anticancer Drugs have drug resistance in the course of clinical application. Therefore, the research of new Anticancer Drugs is imperative. In recent years, with the rapid development of science and technology and advances in molecular oncology and molecular biology technology, new Anticancer Drugs have been discovered.
The "Global Anticancer Drugs Market Research Report 2017" released by QYResearch shows that the revenue of Anticancer Drugs is about 121.25 billion USD in 2016 all around the world. And the Anticancer Drugs market will reach 173.23 billion USD by 2022, with a CAGR 7.4% (2016-2022).


SOURCE QYResearch Global

About QYRessearch

QYRessearch focused on providing customers with a special investigation IPO consulting management consulting industry research seminars and database services, The company has 2,500 customers world-renowned business areas covering more than 30 pharmaceutical and chemical industry, agriculture, energy automotive, business services from the data - Analysis - Recommendations - Consulting floor one-stop solutions, research covering Global and USA South America Europe Middle East Asia-Pacific and Africa and Australia and other regions of the world.For more information please visit:www.qyresearchglobal.com
Contact Person:
Holly Wu
Corporate Sales Specialist,
Molbile: 0086-135-8041-4952
Phone:  86-020-86655165
Email: holly@qyresearch.com